Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma

Background Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. Methods Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant c...

Full description

Bibliographic Details
Main Authors: Hye Eun Park, Seungyeon Yoo, Jeong Mo Bae, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2018-11-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2018-10-02.pdf
_version_ 1828436904093155328
author Hye Eun Park
Seungyeon Yoo
Jeong Mo Bae
Seorin Jeong
Nam-Yun Cho
Gyeong Hoon Kang
author_facet Hye Eun Park
Seungyeon Yoo
Jeong Mo Bae
Seorin Jeong
Nam-Yun Cho
Gyeong Hoon Kang
author_sort Hye Eun Park
collection DOAJ
description Background Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. Methods Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant chemotherapy and/or radiotherapy and who are not associated with familial adenomatous polyposis were selected and 99 tumors from them were subjected to clinicopathologic and molecular analysis. Ninety-two cases of solitary colorectal carcinoma (CRC) were selected as a control considering the distributions of types of surgeries performed on patients with SCRC and T categories of individual tumors from SCRC. Results SCRC with multiple advanced tumors was significantly associated with more frequent nodal metastasis (p = .003) and distant metastasis (p = .001) than solitary CRC. KRAS mutation, microsatellite instability, and CpG island methylator phenotype statuses were not different between SCRC and solitary CRC groups. In univariate survival analysis, overall and recurrence-free survival were significantly lower in patients with SCRC than in patients with solitary CRC, even after adjusting for the extensiveness of surgical procedure, adjuvant chemotherapy, or staging. Multivariate Cox regression analysis revealed that tumor multiplicity was an independent prognostic factor for overall survival (hazard ratio, 4.618; 95% confidence interval, 2.126 to 10.030; p < .001), but not for recurrence-free survival (p = .151). Conclusions Findings suggested that multiplicity of advanced T category–tumors might be associated with an increased risk of nodal metastasis and a risk factor for poor survival, which raises a concern about the guideline of American Joint Committee on Cancer’s tumor-node-metastasis staging that T staging of an index tumor determines T staging of SCRC.
first_indexed 2024-12-10T19:35:34Z
format Article
id doaj.art-c699e7234a554e8783f6753617ac7ccb
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-12-10T19:35:34Z
publishDate 2018-11-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-c699e7234a554e8783f6753617ac7ccb2022-12-22T01:36:08ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452018-11-0152638639510.4132/jptm.2018.10.0216801Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal CarcinomaHye Eun Park0Seungyeon Yoo1Jeong Mo Bae2Seorin Jeong3Nam-Yun Cho4Gyeong Hoon Kang5 Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, KoreaBackground Previous studies on synchronous colorectal carcinoma (SCRC) have reported inconsistent results about its clinicopathologic and molecular features and prognostic significance. Methods Forty-six patients with multiple advanced tumors (T2 or higher category) who did not receive neoadjuvant chemotherapy and/or radiotherapy and who are not associated with familial adenomatous polyposis were selected and 99 tumors from them were subjected to clinicopathologic and molecular analysis. Ninety-two cases of solitary colorectal carcinoma (CRC) were selected as a control considering the distributions of types of surgeries performed on patients with SCRC and T categories of individual tumors from SCRC. Results SCRC with multiple advanced tumors was significantly associated with more frequent nodal metastasis (p = .003) and distant metastasis (p = .001) than solitary CRC. KRAS mutation, microsatellite instability, and CpG island methylator phenotype statuses were not different between SCRC and solitary CRC groups. In univariate survival analysis, overall and recurrence-free survival were significantly lower in patients with SCRC than in patients with solitary CRC, even after adjusting for the extensiveness of surgical procedure, adjuvant chemotherapy, or staging. Multivariate Cox regression analysis revealed that tumor multiplicity was an independent prognostic factor for overall survival (hazard ratio, 4.618; 95% confidence interval, 2.126 to 10.030; p < .001), but not for recurrence-free survival (p = .151). Conclusions Findings suggested that multiplicity of advanced T category–tumors might be associated with an increased risk of nodal metastasis and a risk factor for poor survival, which raises a concern about the guideline of American Joint Committee on Cancer’s tumor-node-metastasis staging that T staging of an index tumor determines T staging of SCRC.http://www.jpatholtm.org/upload/pdf/jptm-2018-10-02.pdfSynchronous colorectal carcinomaMultiple colorectal carcinomaClinical outcomeT category
spellingShingle Hye Eun Park
Seungyeon Yoo
Jeong Mo Bae
Seorin Jeong
Nam-Yun Cho
Gyeong Hoon Kang
Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
Journal of Pathology and Translational Medicine
Synchronous colorectal carcinoma
Multiple colorectal carcinoma
Clinical outcome
T category
title Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
title_full Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
title_fullStr Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
title_full_unstemmed Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
title_short Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
title_sort multiplicity of advanced t category tumors is a risk factor for survival in patients with colorectal carcinoma
topic Synchronous colorectal carcinoma
Multiple colorectal carcinoma
Clinical outcome
T category
url http://www.jpatholtm.org/upload/pdf/jptm-2018-10-02.pdf
work_keys_str_mv AT hyeeunpark multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma
AT seungyeonyoo multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma
AT jeongmobae multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma
AT seorinjeong multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma
AT namyuncho multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma
AT gyeonghoonkang multiplicityofadvancedtcategorytumorsisariskfactorforsurvivalinpatientswithcolorectalcarcinoma